Clinical Trial Update: Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update describing efficacy and safety of Qurevo Plus Ribavirin therapy for chronic hepatitis C in haemodialysis patients, with or without cirrhosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Qurevo Plus Ribavirin Based Therapy

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Hepatitis c | Phase 2 | Status: UNKNOWN